Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping

Journal of Virological Methods

Volumn 134, Issue 1-2, 2006, Pages 252-256

  Seme, Katja ^a   Fujs, Kristina ^a   Kocjan, Boštjan J ^a   Poljak, Mario ^a  

^a UNIVERSITY OF LJUBLJANA   (Slovenia)

Author keywords

Borderline results; hc2; HPV; Hybrid capture

Indexed keywords

VIRUS DNA;

ARTICLE; DIAGNOSTIC ACCURACY; GENOTYPE; HIGH RISK POPULATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS DETECTION; WART VIRUS;

FALSE NEGATIVE REACTIONS; FALSE POSITIVE REACTIONS; FEMALE; GENES, VIRAL; HUMANS; NUCLEIC ACID HYBRIDIZATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; PREDICTIVE VALUE OF TESTS; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY; SPECIES SPECIFICITY;

HUMAN PAPILLOMAVIRUS;

EID: 33646128005     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.12.004     Document Type: Article

References (39)

1. Bernard H.U., Chan S.Y., Manos M.M., Ong C.K., Villa L.L., Delius H., Peyton C.L., Bauer H.M., and Wheeler C.M. Identification and assessment of known and novel human papillomaviruses by polymerase chain reaction amplification, restriction fragment length polymorphisms, nucleotide sequence, and phylogenetic algorithms. J. Infect. Dis. 170 (1994) 1077-1085
2. Castle P.E., Lorincz A.T., Scott D.R., Sherman M.E., Glass A.G., Rush B.B., Wacholder S., Burk R.D., Manos M.M., Schussler J.E., Macomber P., and Schiffman M. Comparison between prototype hybrid capture 3 and hybrid capture 2 human papillomavirus DNA assays for detection of high-grade cervical intraepithelial neoplasia and cancer. J. Clin. Microbiol. 41 (2003) 4022-4030
3. Castle P.E., Wheeler C.M., Solomon D., Schiffman M., Peyton C.L., and ALTS Group. Interlaboratory reliability of Hybrid Capture 2. Am. J. Clin. Pathol. 122 (2004) 238-245
4. Clavel C., Masure M., Bory J.P., Putaud I., Mangeonjean C., Lorenzato M., Nazeyrollas P., Gabriel R., Quereux C., and Birembaut P. Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women. Br. J. Cancer 84 (2001) 1616-1623
5. Cuschieri K.S., and Cubie H.A. The role of human papillomavirus testing in cervical screening. J. Clin. Virol. 32 Suppl. 1 (2005) S34-S42
6. Cuzick J., Beverley E., Ho L., Terry G., Sapper H., Mielzynska I., Lorincz A., Chan W.K., Krausz T., and Soutter P. HPV testing in primary screening of older women. Br. J. Cancer 81 (1999) 554-558
7. Davies P., Kornegay J., and Iftner T. Current methods of testing for human papillomavirus. Best Pract. Res. Clin. Obstet. Gynaecol. 15 (2001) 677-700
8. de Cremoux P., Coste J., Sastre-Garau X., Thioux M., Bouillac C., Labbe S., Cartier I., Ziol M., Dosda A., Le Gales C., Molinie V., Vacher-Lavenu M.C., Cochand-Priollet B., Vielh P., Magdelenat H., and French Society of Clinical Cytology Study Group. Efficiency of the Hybrid Capture 2 HPV DNA Test in cervical cancer screening. A study by the French Society of Clinical Cytology. Am. J. Clin. Pathol. 120 (2003) 492-499
9. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., and zur Hausen H. Classification of papillomaviruses. Virology 324 (2004) 17-27
10. Federschneider J.M., and Crum C.P. HPV testing. Visible expectations and hidden realities. Am. J. Clin. Pathol. 120 (2003) 483-484
11. Federschneider J.M., Yuan L., Brodsky J., Breslin G., Betensky R.A., and Crum C.P. The borderline or weakly positive Hybrid Capture II HPV Test: a statistical and comparative (PCR) analysis. Am. J. Obstet. Gynecol. 191 (2004) 757-761
12. Gravitt P.E., Peyton C.L., Alessi T.Q., Wheeler C.M., Coutlee F., Hildesheim A., Schiffman M.H., Scott D.R., and Apple R.J. Improved amplification of genital human papillomaviruses. J. Clin. Microbiol. 38 (2000) 357-361
13. Gravitt P.E., Burk R.D., Lorincz A., Herrero R., Hildesheim A., Sherman M.E., Bratti M.C., Rodriguez A.C., Helzlsouer K.J., and Schiffman M. A comparison between real-time polymerase chain reaction and Hybrid Capture 2 for human papillomavirus DNA quantitation. Cancer Epidemiol. Biomark. Prev. 12 (2003) 477-484
14. Greer C.E., Peterson S.L., Kiviat N.B., and Manos M.M. PCR amplification from paraffin-embedded tissues: effects of fixative and fixation time. Am. J. Clin. Pathol. 95 (1991) 117-124
15. Iftner T., and Villa L.L. Human papillomavirus technologies. J. Natl. Cancer Inst. Monogr. 31 (2003) 80-88
16. Kocjan B.J., Poljak M., Seme K., Potočnik M., Fujs K., and Babič D.Z. Distribution of human papillomavirus genotypes in plucked eyebrow hairs from Slovenian males with genital warts. Infect. Genet. Evol. 5 (2005) 255-259
17. Kulmala S.M., Syrjanen S., Shabalova I., Petrovichev N., Kozachenko V., Podistov J., Ivanchenko O., Zakharenko S., Nerovjna R., Kljukina L., Branovskaja M., Grunberga V., Juschenko A., Tosi P., Santopietro R., and Syrjanen K. Human papillomavirus testing with the Hybrid Capture 2 assay and PCR as screening tools. J. Clin. Microbiol. 42 (2004) 2470-2475
18. Lörincz A.T. Molecular methods for the detection of human papillomavirus infection. Obstet. Gynecol. Clin. N. Am. 23 (1996) 707-730
19. Lörincz A., and Anthony J. Advances in HPV detection by hybrid capture. Papillomavirus Rep. 12 (2001) 145-154
20. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., Snijders P.J., Meijer C.J., and International Agency for Research on Cancer Multicenter Cervical Cancer Study Group. Epidemiologic classification of human papillomavirus types associated with cervical cancer. New Engl. J. Med. 348 (2003) 518-527
21. Perrons C., Jelley R., Kleter B., Quint W., and Brink N. Detection of persistent high risk human papillomavirus infections with hybrid capture II and SPF10/LiPA. J. Clin. Virol. 32 (2005) 278-285
22. Petry K.U., Menton S., Menton M., van Loenen-Frosch F., de Carvalho Gomes H., Holz B., Schopp B., Garbrecht-Buettner S., Davies P., Boehmer G., van den Akker E., and Iftner T. Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. Br. J. Cancer 88 (2003) 1570-1577
23. Peyton C.L., Schiffman M., Lörincz A.T., Hunt W.C., Mielzynska I., Bratti C., Eaton S., Hildesheim A., Morera L.A., Rodriguez A.C., Herrero R., Sherman M.E., and Wheeler C.M. Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies. J. Clin. Microbiol. 36 (1998) 3248-3254
24. Poljak M., Cerar A., and Seme K. Human papillomavirus infection in esophageal carcinomas: a study of 121 lesions using multiple broad-spectrum polymerase chain reactions and literature review. Hum. Pathol. 29 (1998) 266-271
25. Poljak M., Seme K., and Gale N. Detection of human papillomaviruses in tissue specimens. Adv. Anat. Pathol. 5 (1998) 216-234
26. Poljak M., Brenčič A., Seme K., Vince A., and Marin I.J. Comparative evaluation of first- and second-generation Digene Hybrid Capture assays for detection of human papillomaviruses associated with high or intermediate risk for cervical cancer. J. Clin. Microbiol. 37 (1999) 796-797
27. Poljak M., Marin I.J., Seme K., and Vince A. Hybrid Capture II HPV Test detects at least 15 human papillomavirus genotypes not included in its current high risk cocktail. J. Clin. Virol. 25 Suppl. 3 (2002) S89-S97
28. Poljak M., Fujs K., Seme K., Kocjan B.J., and Vrtačnik-Bokal E. Retrospective and prospective evaluation of the Amplicor HPV Test for detection of 13 high-risk human papillomavirus genotypes on 862 clinical samples. Acta Dermatovenerol. Alp. Panonica Adriat. 14 (2005) 147-152
29. Schneede P., Hillemanns P., Ziller F., Hofstetter A., Stockfleth E., Arndt R., and Meyer T. Evaluation of HPV testing by Hybrid Capture II for routine gynecologic screening. Acta Obstet. Gynecol. Scand. 80 (2001) 750-752
30. Smith R.A., Cokkinides V., Eyre H.J., and American Cancer Society. American Cancer Society guidelines for the early detection of cancer. C.A. Cancer J. Clin. 53 (2003) 27-43
31. Soderlund-Strand A., Rymark P., Andersson P., Dillner J., and Dillner L. Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia. J. Clin. Microbiol. 43 (2005) 3260-3266
32. Solomon D., Schiffman M., Tarone R., and The ALTS Study Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J. Natl. Cancer Inst. 92 (2000) 397-402
33. Terry G., Ho L., Londesborough P., Cuzick J., Mielzynska-Lohnas I., and Lörincz A. Detection of high-risk HPV types by the Hybrid Capture 2 test. J. Med. Virol. 65 (2001) 155-162
34. Tieben L.M., ter Schegget J., Minnaar R.P., Bouwes Bavinck J.N., Berkhout R.J., Vermeer B.J., Jebbink M.F., and Smits H.L. Detection of cutaneous and genital HPV types in clinical samples by PCR using consensus primers. J. Virol. Meth. 42 (1993) 265-279
35. van Doorn L.J., Kleter B., and Quint W.G. Molecular detection and genotyping of human papillomavirus. Expert. Rev. Mol. Diagn. 1 (2001) 394-402
36. Vrtacnik-Bokal E., Rakar S., Jancar N., Mozina A., and Poljak M. Role of human papillomavirus testing in reducing the number of surgical treatments for precancerous cervical lesions. Eur. J. Gynaecol. Oncol. 26 (2005) 427-430
37. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., Snijders P.J., Peto J., Meijer C.J., and Munoz N. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 189 (1999) 12-19
38. Wright Jr. T.C., Cox J.T., Massad L.S., Twiggs L.B., and Wilkinson E.J. ASCCP-Sponsored Consensus Conference, 2002. 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (2002) 2120-2129
39. Yamazaki H., Sasagawa T., Basha W., Segawa T., and Inoue M. Hybrid capture-II and LCR-E7 PCR assays for HPV typing in cervical cytologic samples. Int. J. Cancer 94 (2001) 222-227